Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Modelling the Persistence of Disease-Modifying Drug Treatment (DMT) and its Independent Drivers in Finnish Multiple Sclerosis (MS) Patients: Parametric Survival Modelling.
MS Research Roundup: January 15, 2014
Astrocytes in multiple sclerosis.
Papers: 24 Jul 2015 - 31 Jul 2015
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
Multiple sclerosis: Bigger brains resist disability in MS.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
A rare case of SPG11 mutation with multiple sclerosis.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Papers: 5 Feb 2016 - 12 Feb 2016
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.
MS Research Roundup: July 28, 2014
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Episode 83 with Dr. Jerry Wolinsky on composite clinical trial outcome measures
A New MS Journal
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.

Pages